Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
MS clinical trials: what can subgroup analyses teach us?
Cuprizone neurotoxicity in the rat: morphologic observations.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.

Pages